Akkermansia muciniphila Ameliorates Midlife Obesity-Induced Cognitive Impairment via the Microbiota-Metabolism-Neuroinflammation Axis
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27198771 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Xiaomei Bian und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Laboratory for Clinical Medicine, Laboratory of Organ Synergy and Int…. Hauptthemen laut MEDLINE: Obesity, Cognitive Dysfunction, Gastrointestinal Microbiome, Neuroinflammatory Diseases. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Young Scientists Fund of the National Natural Science Foundation of China.
Abstract (Originalsprache)
Midlife obesity is an established independent risk factor for age-related cognitive decline, yet direct causal experimental evidence and underlying gut microbial mechanisms remain poorly defined. Using a mouse model of high-fat diet (HFD)-induced obesity restricted to the midlife period (6–12 months of age) in male wild-type C57BL/6J mice, we characterized the temporal and causal relationship between midlife weight gain and cognitive deterioration, and investigated the mediating function of Akkermansia muciniphila (Akk). Longitudinal body weight tracking across the lifespan revealed a stage-specific dynamic pattern, with sustained adipose tissue accumulation occurring during the midlife period (6–12 months of age). Midlife HFD exposure triggered multi-dimensional cognitive deficits accompanied by significant depletion of intestinal Akk, while oral supplementation of Akk effectively attenuated HFD-induced weight gain and ameliorated spatial, recognition and contextual memory impairments. Mechanistically, Akk suppressed hippocampal glial hyperactivation and proinflammatory factor upregulation, attenuated neuronal loss, and preserved hippocampal synaptic integrity. Serum metabolomics further identified midlife-specific metabolic remodeling characterized by dysregulated lipid metabolism and depleted microbiota-derived indole metabolites. Our findings establish a causal link between midlife obesity and accelerated cognitive aging, and identify Akk as a promising early intervention target for age-related cognitive decline.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Laboratory for Clinical Medicine, Laboratory of Organ Synergy and Intelligent Regenerative Manufacturing, Capital Medical University, Beiji…
- School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Young Scientists Fund of the National Natural Science Foundation of China
- School of Basic Medical Sciences, Capital Medical University
Zitieren
APA
Bian, X., Cao, J., He, A., Jian, W., Wang, W., & Zha, X. (2026). Akkermansia muciniphila Ameliorates Midlife Obesity-Induced Cognitive Impairment via the Microbiota-Metabolism-Neuroinflammation Axis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27198771
Vancouver
Bian X, Cao J, He A, Jian W, Wang W, Zha X. Akkermansia muciniphila Ameliorates Midlife Obesity-Induced Cognitive Impairment via the Microbiota-Metabolism-Neuroinflammation Axis. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27198771
BibTeX
@article{Bian2026,
author = {Bian, Xiaomei and Cao, Jiaqi and He, Anrui and Jian, Weiran and Wang, Wei and Zha, Xu},
title = {Akkermansia muciniphila Ameliorates Midlife Obesity-Induced Cognitive Impairment via the Microbiota-Metabolism-Neuroinflammation Axis},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27198771}
}
EUVIMED